Irinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTC | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Irinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTC	Biliary Tract Carcinoma	Not yet recruiting	Phase 2	2024-11-21		NCT06699459

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
First Affiliated Hospital, Sun Yat-Sen University	113
Fujian Provincial Hospital	45
Ningbo No. 1 Hospital	31
RenJi Hospital	264
Shaoxing People's Hospital	24
Sir Run Run Shaw Hospital	117
Southern Medical University, China	37
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine	91
Zhejiang Cancer Hospital	142

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Fujian Provincial Hospital	Fuzhou	China	3
Renji Hospital, Shanghai Jiao Tong University School of Medicine	Shanghai	China	2
Sir Run Run Shaw Hospital , affiliated with the Zhejiang University School of Medicine	Hangzhou	China	2
The First Affiliated Hospital, Sun Yat-sen University	Guangzhou	China	32
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine	Shanghai	China	6
Zhejiang Cancer Hospital	Hangzhou	China	34